Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Novartis

This article was originally published in The Tan Sheet

Executive Summary

Michael Valentino, chief operating officer of Novartis Consumer Health in North America, promoted to exec VP and global head of Novartis Consumer Health OTC. Also, Frank Palantoni, global head of the Infant & Baby business, will assume additional responsibilities of CEO-North America, overseeing all U.S. and Canadian operations of the five consumer health segments - Gerber Products, OTC, Medical Nutrition, Health & Functional Nutrition and Pacific Life Foods. The Gerber brand was expanded earlier this year with a line of OTCs and hygiene products (1"The Tan Sheet" Jan. 17, p. 6)

You may also be interested in...



Gerber OTC, Hygiene Product Extensions Launching In March

Novartis Consumer Health is expanding its market-leading Gerber brand of baby food and care items with a series of OTC and hygiene products. The Gerber Wellness line should reach full nationwide distribution by the end of March.

Supplement GMP Warning Letters Make Modest Debut In 2010

Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC

In Brief

Combe sells most of its OTC brands

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS091826

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel